Brief: Vera Therapeutics Says Co's Preliminary Unaudited Cash, Cash Equivalents And Marketable Securities As Of Dec 31, 2023 Were About $160.7 Mln

Vera Therapeutics

29/01/2024 11:28

Jan 29 (Reuters) - Vera Therapeutics Inc  VERA.O :
    * VERA THERAPEUTICS INC: PRELIMINARY UNAUDITED CASH, CASH
EQUIVALENTS AND MARKETABLE SECURITIES AS OF DEC 31, 2023 WERE
ABOUT $160.7 MILLION
    * VERA THERAPEUTICS: SUSPENDED,TERMINATED ATM PROSPECTUS
RELATED
TO AN AT MARKET OFFERING PURSUANT TO SALES AGREEMENT DATED JUNE
3, 2022
    * VERA THERAPEUTICS INC: OTHER THAN TERMINATION OF ATM
PROSPECTUS,
SALES AGREEMENT REMAINS IN FULL FORCE AND EFFECT

Source text for Eikon:  ID:n0001193125-24-017311 
Further company coverage:  VERA.O 

 ((Reuters.Briefs@thomsonreuters.com;))